Fox Space source of local, national and world news
Pharmaceutical supply chains face persistent supply-demand imbalances driven by global demand for metabolic therapies. Drug manufacturers are allocating billions toward dedicated contract manufacturing capacity.
Infrastructure Investment
Contract Development and Manufacturing Organizations are expanding specialized cold-chain logistics networks. Market projections indicate capacity bottlenecks will persist through mid-2026 despite heavy capital expenditure.
Pharmaceutical manufacturers expand Phase III clinical trials for oral obesity therapies as injectable capacity bottlenecks ease.
Phase III trials demonstrate significant reductions in adverse cardiac events among non-diabetic patient cohorts.
Widespread adoption of GLP-1 receptor agonists is driving significant structural changes across metabolic disease management and connected medical…
De novo computational drug design reduces early-stage oncology target selection timelines by 60%.
Hospital networks deploy machine learning algorithms to reduce diagnostic latency and optimize patient triage in emergency departments.
Widely blamed for weight, widely misunderstood, and less variable between people than assumed.